DE602005024245D1 - Tricyclische benzopyranverbindungen als antiarrhythmika - Google Patents

Tricyclische benzopyranverbindungen als antiarrhythmika

Info

Publication number
DE602005024245D1
DE602005024245D1 DE602005024245T DE602005024245T DE602005024245D1 DE 602005024245 D1 DE602005024245 D1 DE 602005024245D1 DE 602005024245 T DE602005024245 T DE 602005024245T DE 602005024245 T DE602005024245 T DE 602005024245T DE 602005024245 D1 DE602005024245 D1 DE 602005024245D1
Authority
DE
Germany
Prior art keywords
group
hydrogen atom
ring
atom
bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005024245T
Other languages
German (de)
English (en)
Inventor
Kazuhiko Ohrai
Yukihiro Shigeta
Osamu Uesugi
Takumi Okada
Tomoyuki Matsuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Publication of DE602005024245D1 publication Critical patent/DE602005024245D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602005024245T 2004-03-23 2005-03-23 Tricyclische benzopyranverbindungen als antiarrhythmika Expired - Lifetime DE602005024245D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004084605 2004-03-23
PCT/JP2005/006004 WO2005090357A1 (en) 2004-03-23 2005-03-23 Tricyclic benzopyran compound as anti-arrhythmic agents

Publications (1)

Publication Number Publication Date
DE602005024245D1 true DE602005024245D1 (de) 2010-12-02

Family

ID=34962589

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024245T Expired - Lifetime DE602005024245D1 (de) 2004-03-23 2005-03-23 Tricyclische benzopyranverbindungen als antiarrhythmika

Country Status (30)

Country Link
US (2) US7652008B2 (https=)
EP (1) EP1732929B1 (https=)
JP (1) JP4840594B2 (https=)
KR (2) KR101085979B1 (https=)
CN (3) CN102190661B (https=)
AT (1) ATE485299T1 (https=)
AU (2) AU2005223612B2 (https=)
BR (1) BRPI0508768A (https=)
CA (1) CA2558139C (https=)
CY (1) CY1111250T1 (https=)
CZ (1) CZ2006598A3 (https=)
DE (1) DE602005024245D1 (https=)
DK (1) DK1732929T3 (https=)
EG (1) EG27163A (https=)
ES (1) ES2353021T3 (https=)
HR (1) HRP20110005T1 (https=)
IL (1) IL177950A (https=)
MX (1) MXPA06010880A (https=)
NO (1) NO339495B1 (https=)
NZ (2) NZ549570A (https=)
PL (1) PL1732929T3 (https=)
PT (1) PT1732929E (https=)
RS (1) RS51742B (https=)
RU (1) RU2380370C2 (https=)
SI (1) SI1732929T1 (https=)
SK (1) SK287994B6 (https=)
TW (1) TWI352704B (https=)
UA (1) UA91189C2 (https=)
WO (1) WO2005090357A1 (https=)
ZA (1) ZA200607388B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2353021T3 (es) * 2004-03-23 2011-02-24 Nissan Chemical Industries, Ltd. Compuesto de benzopirano tricíclico como agentes anti-arrítmicos.
RU2448112C2 (ru) 2006-03-10 2012-04-20 Ниссан Кемикал Индастриз, Лтд. Способ получения оптически активного соединения оксида хромена
TW201022223A (en) * 2008-08-14 2010-06-16 Nissan Chemical Ind Ltd Di-substituted benzopyrane compound
KR101703202B1 (ko) * 2009-04-30 2017-02-06 닛산 가가쿠 고교 가부시키 가이샤 3환성 벤조피란 화합물의 신규한 결정형태 및 그 제조방법
US8431576B2 (en) 2009-06-25 2013-04-30 Alkermes Pharma Ireland Limited Heterocyclic compounds for the treatment of neurological and psychological disorders
JPWO2014051077A1 (ja) * 2012-09-27 2016-08-25 日産化学工業株式会社 高純度の含窒素複素環化合物の製造方法
JP6202280B2 (ja) * 2012-09-27 2017-09-27 日産化学工業株式会社 含窒素複素環n−オキシド化合物の製造方法
JPWO2015012271A1 (ja) * 2013-07-25 2017-03-02 日産化学工業株式会社 複素環化合物の製造方法
US11168094B2 (en) 2017-01-06 2021-11-09 Azcuris Co., Ltd. Quinolinone derivative and pharmaceutical composition for preventing or treating allergic diseases such as asthma or atopic dermatitis including the quinolinone derivative as active ingredient
EP3761983A1 (en) 2018-03-05 2021-01-13 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN108727261B (zh) * 2018-06-21 2021-09-24 济南大学 一种硝基取代喹那啶的制备方法
US20220071951A1 (en) * 2018-12-28 2022-03-10 Osaka University Therapeutic agent for inherited bradyarrhythmia
RU2754610C1 (ru) * 2020-04-14 2021-09-03 Георгий Викторович ТЕЦ Препарат для лечения заболеваний, вызванных бактериями
CN115916201B (zh) * 2020-06-26 2024-09-17 国立大学法人大阪大学 药剂诱发性心动过缓及心动过缓性心律失常治疗药

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
JPS5867683U (ja) 1981-10-28 1983-05-09 株式会社ナムコ 歩行ロボツト
JPH0699439B2 (ja) * 1988-02-03 1994-12-07 日産化学工業株式会社 ピラノベンゾオキサジアゾール誘導体
JP2658198B2 (ja) * 1988-06-23 1997-09-30 日産化学工業株式会社 ピラノベンゾトリアゾール誘導体
JP2876712B2 (ja) * 1989-07-17 1999-03-31 日産化学工業株式会社 光学活性ピラノベンゾオキサジアゾール誘導体
US5097037A (en) * 1989-07-17 1992-03-17 Nissan Chemical Industries, Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
US5164509A (en) * 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs
JPH07300414A (ja) * 1993-04-02 1995-11-14 Nissan Chem Ind Ltd 心不全治療薬
UA27973C2 (uk) * 1993-04-02 2000-10-16 Ніссан Кемікал Індастріз Лтд Лікарський засіб для лікування серцевої недостатності
JP2734457B2 (ja) 1994-02-23 1998-03-30 日産化学工業株式会社 不斉エポキシ化反応
WO1995034547A1 (en) * 1994-06-10 1995-12-21 Smithkline Beecham Plc C-4 amide substituted compounds and their use as therapeutic agents
HRP970255B1 (en) * 1996-05-15 2003-10-31 Hoechst Ag Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents as well as medicaments containing them
US6486178B1 (en) 1998-06-03 2002-11-26 Nissan Chemical Industries, Ltd. Indane derivatives
AU5444499A (en) 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
AU2830800A (en) 1999-03-25 2000-10-16 Nissan Chemical Industries Ltd. Chroman derivatives
CA2383583C (en) * 1999-09-17 2009-04-07 Nissan Chemical Industries, Ltd. Benzopyran derivative
EP1214307B1 (en) 1999-09-24 2004-04-07 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6677371B1 (en) 1999-10-05 2004-01-13 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
EP1401823B1 (en) 2001-06-25 2005-10-05 Nissan Chemical Industries, Ltd. Substituted benzopyran derivatives against arrhythmia
WO2003014113A1 (en) 2001-08-06 2003-02-20 Glenmark Pharmaceuticals Limited Novel benzopyran compounds and process for their preparation and use
ES2353021T3 (es) * 2004-03-23 2011-02-24 Nissan Chemical Industries, Ltd. Compuesto de benzopirano tricíclico como agentes anti-arrítmicos.

Also Published As

Publication number Publication date
NZ549570A (en) 2010-08-27
TW200600509A (en) 2006-01-01
RU2380370C2 (ru) 2010-01-27
IL177950A (en) 2013-04-30
ES2353021T3 (es) 2011-02-24
EP1732929A1 (en) 2006-12-20
AU2005223612A1 (en) 2005-09-29
CA2558139A1 (en) 2005-09-29
ZA200607388B (en) 2008-07-30
AU2010202900A1 (en) 2010-07-29
AU2010202900B2 (en) 2011-10-27
RU2006137284A (ru) 2008-04-27
JP2007530436A (ja) 2007-11-01
NO339495B1 (no) 2016-12-19
KR101085979B1 (ko) 2011-11-22
RS51742B (sr) 2011-10-31
PL1732929T3 (pl) 2011-04-29
US20100069374A1 (en) 2010-03-18
MXPA06010880A (es) 2006-12-15
CN1934116A (zh) 2007-03-21
CY1111250T1 (el) 2015-06-11
JP4840594B2 (ja) 2011-12-21
WO2005090357A1 (en) 2005-09-29
CN101429200B (zh) 2012-05-30
AU2005223612B2 (en) 2010-06-24
HK1099299A1 (en) 2007-08-10
PT1732929E (pt) 2010-12-21
CA2558139C (en) 2012-01-17
KR101019402B1 (ko) 2011-03-07
KR20100130249A (ko) 2010-12-10
SK50792006A3 (sk) 2007-09-06
US20080004262A1 (en) 2008-01-03
IL177950A0 (en) 2006-12-31
SK287994B6 (sk) 2012-09-03
US7652008B2 (en) 2010-01-26
UA91189C2 (en) 2010-07-12
ATE485299T1 (de) 2010-11-15
KR20070009638A (ko) 2007-01-18
NO20064819L (no) 2006-10-23
CN101429200A (zh) 2009-05-13
HRP20110005T1 (hr) 2011-02-28
DK1732929T3 (da) 2010-12-20
TWI352704B (en) 2011-11-21
SI1732929T1 (sl) 2010-12-31
US7964623B2 (en) 2011-06-21
NZ585606A (en) 2011-11-25
EG27163A (en) 2015-08-24
EP1732929B1 (en) 2010-10-20
CN102190661A (zh) 2011-09-21
CN1934116B (zh) 2012-10-10
BRPI0508768A (pt) 2007-02-27
CN102190661B (zh) 2013-07-31
CZ2006598A3 (cs) 2006-11-15

Similar Documents

Publication Publication Date Title
CY1111250T1 (el) Τρικυκλικη ενωση βενζοπυρανιου με ιδιοτητα αντιαρρυθμικων παραγοντων
HUP0300138A2 (en) Cyclic amine derivatives as ccr5 antagonists, their production and use and pharmaceutical compositions containing them
MY139988A (en) Macrocylic inhibitors of hepatitis c virus
YU79502A (sh) Novi,sporodelujući betamimetici,postupak za njihovo pripremanje i njihova primena kao lekova
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
MX9504287A (es) Derivados de camptotecina y proceso para su preparacion.
BG105969A (en) Amine derivatives as protein inhibitors
EP1719761A4 (en) NEW HETEROCYCLIC CONNECTION
EP0798292A4 (en) ANILINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE INHIBITORS
EP1479684A4 (en) THIENOPYRIMIDINES, METHODS OF MAKING AND USING SAME
DE60203290D1 (de) Oxytocin agonisten
ATE165095T1 (de) Heterocyclische derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE69328366D1 (de) Benzopyran und benzoxazin-derivate
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
AR035375A1 (es) Compuesto derivado de pirrol sustituido, composicion farmaceutica y su uso en la fabricacion de un medicamento para inhibir la farnesiltransferasa
MXPA02007973A (es) Compuestos de aminoacidos y su uso como inhibidores de nep, ace y ece.
MY138865A (en) New tricyclic azepine compounds, a process for their preparation and pharmaceutical compositions containing them
DE60106168D1 (de) Substituierte 1-aza-2-imino-heterocyclen und ihre verwendung als aktivatoren der nikotinergen acetylcholinrezeptoren
IL136510A0 (en) Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same
DE60239491D1 (de) Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung
AR034088A1 (es) Composicion que comprende derivados anticonvulsivantes utiles en el tratamiento de esquizofrenia y el uso de dicho derivado para la manufactura de un medicamento
DE60008396D1 (de) Amidderivate
DE60221894D1 (de) Vollständige synthese der galanthamin, deren analogen und derivaten
MY129238A (en) Anticonvulsant derivatives useful in treating essential tremor
ATE429239T1 (de) 18-gliedrige nitrobenzyl- und aminobenzyl- substituierte cyclohexadepsipeptide zur bekämpfung von endoparasiten und ein verfahren zu ihrer herstellung